Declining trend in transmission of drug-resistant HIV-1 in Amsterdam

AIDS

Volumn 18, Issue 11, 2004, Pages 1571-1577

  Bezemer, Daniela ^a,e   Jurriaans, Suzanne ^a   Prins, Maria ^a   Van Der Hoek, Lia ^a   Prins, Jan M ^b   De Wolf, Frank ^c,d   Berkhout, Ben ^a   Coutinho, Roel ^a   Back, Nicole K T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c STICHTING HIV MONITORING   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

Cohort; HIV 1; Resistance associated mutations; Therapy; Transmission

Indexed keywords

PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MUTATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIMARY INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROCONVERSION; TIME; VIRUS STRAIN; VIRUS TRANSMISSION; WILD TYPE;

ADULT; COHORT STUDIES; DRUG RESISTANCE, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; NETHERLANDS; PREVALENCE; RISK FACTORS; RNA, VIRAL;

EID: 3843052426     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000131357.52457.33     Document Type: Article

References (33)

1. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347:385-394.
2. Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 2002; 288:181-188.
3. Simon V, Vanderhoeven J, Hurley A, Ramratnam B, Louie M, Dawson K, et al. Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals. AIDS 2002; 16:1511-1519.
4. UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 2001; 322:1087-1088.
5. Ammaranond P, Cunningham P, Oelrichs R, Suzuki K, Harris C, Leas L, et al. No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001. AIDS 2003; 17:264-267.
6. Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, et al. Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment. AIDS 2002; 16:793-796.
7. Yerly S, Vora S, Rizzardi P, Chave JP, Vernazza PL, Flepp M, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 2001; 15:2287-2292.
8. Hirsch MS, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003; 37:113-128.
9. Kuritzkes DR. A fossil record of zidovudine resistance in transmitted isolates of HIV-1. Proc Natl Acad Sci USA 2001; 98:13485-13487.
10. Brenner B, Wainberg MA, Salomon H, Rouleau D, Dascal A, Spira B, et al. Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study. Int J Antimicrob Agents 2000; 16:429-434.
11. van Griensven GJ, Tielman RA, Goudsmit J, van der Noordaa J, de Wolf F, de Vroome EM, et al. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987; 125:1048-1057.
12. van den Hoek JA, Coutinho RA, van Haastrecht HJ, van Zadelhoff AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988; 2:55-60.
13. Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001; 17:137-146.
14. de Jong JJ, Goudsmit J, Lukashov VV, Hillebrand ME, Baan E, Huismans R, et al. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. AIDS 1999; 13: 75-80.
15. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
16. D'Aquila RT, Schapiro JM, Brun-Vezinet F, Clotet B, Conway B, Demeter LM, et al. Drug resistance mutations in HIV-1. Top HIV Med 2003; 11:92-96.
17. Garcia-Lerma JG, Nidtha S, Blumoff K, Weinstock H, Heneine W. Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. Proc Natl Acad Sci USA 2001; 98:13907-13912.
18. de Ronde A, van Dooren M, van der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, et al. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J Virol 2001; 75:595-602.
19. Yerly S, Rakik A, De Loes SK, Hirschel B, Descamps D, Brun-Vezinet F, et al. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol 1998; 72:3520-3523.
20. Kuiken C, Korber B, Shafer RW. HIV sequence databases. AIDS Rev 2003; 5:52-61.
21. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16:111-120.
22. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4:406-425.
23. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001; 17:1244-1245.
24. Ray SC. SimPlot. Baltimore, MD, USA: Division of Infectious Diseases, Johns Hopkins University School of Medicine; 1998. http://sray.med.som.jhmi.edu/ RaySoft/SimPlot/.
25. Veugelers PJ, Kaldor JM, Strathdee SA, Page-Shafer KA, Schlechter MT, Coutinho RA, et al. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis 1997; 176:172-717.
26. Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS 2003; 17:1925-1932.
27. Goudsmit J, Weverling GJ, van der Hoek L, de Ronde A, Miedema F, Coutinho RA, et al. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistance strains. AIDS 2001; 15:2293-2301.
28. Gras L, van Sighem A, van Valkengoed I, de Wolf F. for the Dutch Collaborative HIV treatment Centers. Monitoring of Human Immunodeficiency Virus Type 1 (HIV-1) in the Netherlands. Amsterdam: Stichting HIV Monitoring; 2002.
29. Gras L, van Sighem A, Zaheri S, van Valkengoed I, de Wolf F. for the Dutch Collaborative HIV treatment Centers. Monitoring of Human Immunodeficiency Virus Type 1 (HIV-1) in the Netherlands. Amsterdam: Stichting HIV Monitoring; 2003.
30. Stolte IG, Coutinho RA. Risk behaviour and sexually transmitted diseases are on the rise in gay men, but what is happening with HIV? Curr Opin Infect Dis 2002; 15:37-41.
31. Op de Coul EL, Lukashov VV, van Doornum GJ, Goudsmit J, Coutinho RA. Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988-1996: no evidence for spread of non-B subtypes. AIDS 1998; 12:1253-1255.
32. Back NK, Nijhuis M, Keulen W, Boucher CA, Oude EB, van Kuilenburg AB, et al. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J 1996; 15:4040-4049.
33. de Ronde A, van Dooren M, van Der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, Goudsmit J. Establishment of new transmissable and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J Virol 2001; 75: 595-602.